Tocilizumab monotherapy uncovered the role of the CCL22/17‐CCR4+Treg axis during remission of crescentic glomerulonephritis-Reference-Cited by-同舟云学术

Tocilizumab monotherapy uncovered the role of the CCL22/17‐CCR4+Treg axis during remission of crescentic glomerulonephritis

Published:2020-01 Issue:11 Volume:9 Page:
ISSN:2050-0068
Container-title:Clinical & Translational Immunology
language:en
Short-container-title:Clin. Transl. Immunol.

Author:

Sakai Ryota¹²^ORCID,Ito Minako¹,Yoshimoto Keiko³,Chikuma Shunsuke¹,Kurasawa Takahiko²,Kondo Tsuneo²,Suzuki Katsuya³,Takeuchi Tsutomu³,Amano Koichi²,Yoshimura Akihiko¹

Affiliation:

1. Department of Microbiology and Immunology Keio University School of Medicine Tokyo Japan

2. Department of Rheumatology and Clinical Immunology Saitama Medical CenterSaitama Medical University Kawagoe Japan

3. Division of Rheumatology Department of Internal Medicine Keio University School of Medicine Tokyo Japan

Funder

Takeda Science Foundation

Uehara Memorial Foundation

Mochida Memorial Foundation for Medical and Pharmaceutical Research

Kanae Foundation for the Promotion of Medical Science

SENSHIN Medical Research Foundation

Publisher

Wiley

Subject

General Nursing,Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cti2.1203

Reference50 articles.

1. Tocilizumab in patients with adult-onset still’s disease refractory to glucocorticoid treatment: a randomised, double-blind, placebo-controlled phase III trial

2. Trial of Tocilizumab in Giant-Cell Arteritis

3. Efficacy and safety of tocilizumab in patients with refractory Takayasu arteritis: results from a randomised, double-blind, placebo-controlled, phase 3 trial in Japan (the TAKT study)

4. Interleukin-6 in ANCA-associated vasculitis: Rationale for successful treatment with tocilizumab

5. Corticosteroid- and cyclophosphamide-free treatment of anti-neutrophil cytoplasmic antibody-associated vasculitis using tocilizumab

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Percutaneous Delivery of Hederacoside C-Loaded Nanoliposome Gel Alleviates Psoriasiform Skin Inflammation through the CCL17/Treg Axis;ACS Applied Materials & Interfaces;2024-09-05

2. Successful maintenance therapy with tocilizumab for severe acute liver failure associated with adult-onset still’s disease;Immunological Medicine;2024-08-05

3. Targeting Monocyte Derived CCL17 Attenuates Murine Crescentic Glomerulonephritis by Affecting Renal CCR4+ Regulatory T-Cell Recruitment;American Journal of Nephrology;2023-09-23

4. CCL17 acts as an antitumor chemokine in micromilieu‐driven immune skewing;International Immunopharmacology;2023-05

5. E. coli LPS/TLR4/NF-κB Signaling Pathway Regulates Th17/Treg Balance Mediating Inflammatory Responses in Oral Lichen Planus;Inflammation;2023-04-05